{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T17:42:18Z","timestamp":1774374138423,"version":"3.50.1"},"reference-count":23,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"vor","delay-in-days":273,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1016\/j.medici.2014.09.004","type":"journal-article","created":{"date-parts":[[2014,10,2]],"date-time":"2014-10-02T16:48:29Z","timestamp":1412268509000},"page":"197-203","source":"Crossref","is-referenced-by-count":10,"title":["Guidelines for diagnostics and treatment of aromatase inhibitor-induced bone loss in women with breast cancer"],"prefix":"10.3390","volume":"50","author":[{"given":"Elona","family":"Juozaityt\u0117","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardas","family":"Aleknavi\u010dius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasa","family":"Jan\u010diauskien\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvydas","family":"\u010cesas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teres\u0117","family":"Pipirien\u0117-\u017delvien\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigita","family":"Liutkauskien\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelija","family":"Krasauskien\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Vencevi\u010dien\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","reference":[{"issue":"5","key":"10.1016\/j.medici.2014.09.004_bib0005","first-page":"272","article-title":"Survival of women with breast cancer in Kaunas Region, Lithuania","volume":"48","author":"Ivanauskien\u0117","year":"2012","journal-title":"Medicina (Kaunas)"},{"issue":"6","key":"10.1016\/j.medici.2014.09.004_bib0010","first-page":"365","article-title":"Management of cancer treatment-induced bone loss","volume":"9","author":"Coleman","year":"2013","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.medici.2014.09.004_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ctrv.2008.03.007","article-title":"Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group","volume":"34","author":"Reid","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.medici.2014.09.004_bib0020","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.2005.02.7102","article-title":"Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group","volume":"25","author":"Gnant","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.medici.2014.09.004_bib0025","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/annonc\/mdr356","article-title":"Fracture incidence after 3 years of aromatase inhibitor therapy","volume":"23","author":"Bouvard","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.medici.2014.09.004_bib0030","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1007\/s00198-011-1870-0","article-title":"Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper","volume":"23","author":"Rizzoli","year":"2012","journal-title":"Osteoporosis"},{"key":"10.1016\/j.medici.2014.09.004_bib0035","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000321426","article-title":"Guidelines for osteoprotection in breast cancer patients on an aromatase inhibitor","volume":"5","author":"Hadji","year":"2010","journal-title":"Breast Care"},{"key":"10.1016\/j.medici.2014.09.004_bib0040","article-title":"Osteoporoz\u0117s diagnostikos ir gydymo rekomendacijos 2011 m. (2011 guidelines for diagnostics and treatment of osteoporosis.)","volume":"8","author":"Alekna","year":"2011","journal-title":"Internistas"},{"key":"10.1016\/j.medici.2014.09.004_bib0045","first-page":"680","article-title":"Kaul\u0173 mas\u0117s ma\u017e\u0117jimo, taikant androgen\u0173 deprivacijos terapij\u0105 prostatos v\u0117\u017eiui gydyti, diagnostikos ir gydymo rekomendacijos. (Guidelines for diagnostics and treatment of bone loss by application of androgen deprivation therapy for prostate cancer.)","volume":"9","author":"Jievaltas","year":"2011","journal-title":"Lietuvos bendrosios praktikos gydytojas"},{"key":"10.1016\/j.medici.2014.09.004_bib0050","series-title":"Osteoporoz\u0117s ambulatorinio gydymo kompensuojamaisiais vaistais tvarkos apra\u0161as. (Order of inpatient osteoporosis treatment with reimbursed drugs.)","year":"2014"},{"issue":"1","key":"10.1016\/j.medici.2014.09.004_bib0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"24","author":"Kanis","year":"2013","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.medici.2014.09.004_bib0060","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jbspin.2012.02.014","article-title":"2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis","volume":"79","author":"Briot","year":"2012","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.medici.2014.09.004_bib0065","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00198-007-0439-4","article-title":"Management of cancer treatment-induced bone loss in early breast and prostate cancer \u2013 a consensus paper of the Belgian bone club","volume":"18","author":"Body","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.medici.2014.09.004_bib0070","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1016\/j.breast.2007.07.029","article-title":"Fertility and adjuvant treatment in young women with breast cancer","volume":"16","author":"Partridge","year":"2007","journal-title":"Breast"},{"key":"10.1016\/j.medici.2014.09.004_bib0075","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1200\/JCO.1996.14.5.1718","article-title":"Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer","volume":"14","author":"Bines","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.medici.2014.09.004_bib0080","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1200\/JCO.2001.19.14.3306","article-title":"Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer","volume":"19","author":"Shapiro","year":"2001","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.medici.2014.09.004_bib0085","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJM199203263261302","article-title":"Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer","volume":"326","author":"Love","year":"1992","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.medici.2014.09.004_bib0090","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1200\/JCO.2007.11.0726","article-title":"Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230","author":"Eastell","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.medici.2014.09.004_bib0095","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1093\/annonc\/mdr017","article-title":"Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment","volume":"12","author":"Hadji","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.medici.2014.09.004_bib0100","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc3055","article-title":"Cancer to bone: a fatal attraction","author":"Weilbaecher","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.medici.2014.09.004_bib0105","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medici.2014.09.004_bib0110","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1200\/JCO.2008.16.3832","article-title":"Randomized trial of denosumab in patients receiving adjunvant aromatase inhibitors for nonmetastatic breast cancer","volume":"30","author":"Ellis","year":"2008","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.medici.2014.09.004_bib0115","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1007\/s00198-013-2530-3","article-title":"Cancer-associated bone disease","volume":"24","author":"Rizzoli","year":"2013","journal-title":"Osteoporos Int"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1010660X1400069X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1010660X1400069X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T15:51:58Z","timestamp":1565884318000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1010660X1400069X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"alternative-id":["S1010660X1400069X"],"URL":"https:\/\/doi.org\/10.1016\/j.medici.2014.09.004","relation":{},"ISSN":["1010-660X"],"issn-type":[{"value":"1010-660X","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}